TBC1D3 antibody (C-Term)
Quick Overview for TBC1D3 antibody (C-Term) (ABIN7185578)
Target
See all TBC1D3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Purpose
- TBC1D3/TBC1D3B/TBC1D3C Antibody
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the C-terminal region of Human TBC1D3A/B/C.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- TBC1D3 (TBC1 Domain Family, Member 3 (TBC1D3))
-
Alternative Name
- TBC1D3
-
Background
- TBC1D3, PRC17, TBC1D3A, TBC1 domain family member 3, Prostate cancer gene 17 protein, Protein TRE17-alpha, Rab GTPase-activating protein PRC17, TBC1D3B, TBC1D3I, TBC1 domain family member 3B, TBC1D3C, TBC1D3D, TBC1 domain family member 3C
-
UniProt
- Q8IZP1, A6NDS4, Q6IPX1
Target
-